Merck to submit its experimental COVID-19 oral treatment for emergency use authorization

FAN Editor 3 years ago

Merck to submit its experimental COVID-19 oral treatment for emergency use authorization – CBS News

Watch CBSN Live


Pharmaceutical company Merck says its experimental pill significantly reduces the effects of COVID-19 and plans to submit its findings to the Food and Drug Administration for emergency use authorization. CBS News researcher Max Bayer speaks with CBSN’s Tanya Rivero about how this drug differs from those already in use.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.

Free America Network Articles

Leave a Reply

Next Post

Live Updates: Houston police respond to reports of school shooting

Fri Oct 1 , 2021
Police said Friday they were responding to reports of a shooting at a school in southwest Houston. They later said one suspect was in custody and they were looking for any other possible suspects. The scene was still active midday Friday and law enforcement was working to secure the location, […]

You May Like